Pontifax Management 4 G.P. (2015) Ltd.'s Net Worth

$0

Estimate Recalculated Nov 11, 2024 08:46AM EST

Who is Pontifax Management 4 G.P. (2015) Ltd.?

Pontifax Management 4 G.P. (2015) Ltd. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Keros Therapeutics, Inc., 89bio, Inc., and Eloxx Pharmaceuticals, Inc..

SEC CIK

Pontifax Management 4 G.P. (2015) Ltd.'s CIK is 0001726334

Past Insider Trading and Trends

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

89bio, Inc. (ETNB) Snapshot price: $8.47

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
1.13M
$16.00
—
1.13M
Nov 11 - Nov 13
Form 3
—
0
—
—
0
No matching records found

Keros Therapeutics, Inc. (KROS) Snapshot price: $52.51

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-0.15%
-7.18K
—
-$0.71
4.63M
Nov 29
Form 3/A
—
0
—
—
0
Form 4
+1.27%
60K
$50.00
$3,000,000.00
4.79M
Nov 17
Form 4
+31.88%
3.98M
$16.00
$6,999,984.00
16.48M
Apr 13
Form 3
—
0
—
—
0
No matching records found

Eloxx Pharmaceuticals, Inc. (ELOX) Snapshot price: $0.82

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+275.43%
5.93M
$1.35
$7,999,998.75
8.08M
May 13
Form 4
—
0
—
—
0
May 20
Form 4
+10.25%
200K
$9.00
$1,800,000.00
2.15M
Jun 24
Form 4
—
0
—
—
0
May 29
Form 4
—
0
—
—
0
Jun 15
Form 4
+21.85%
350K
$9.75
$3,412,500.00
1.95M
Apr 30
Form 4
+0.40%
12.6K
$7.78
$97,830.00
3.2M
Mar 21 - Mar 22
Form 3
—
0
—
—
0
No matching records found